Review Article - (2013) Volume 2, Issue 4

Safety and Tolerability of EPs 7630 in Clinical Trials

Heinrich Matthys1*, Stephan Köhler2 and Wolfgang Kamin3
1Medical Director emeritus, Department of Pneumology, University Hospital Freiburg, Freiburg, Germany
2ClQualified Person for Pharmacovigilance, Clinical Research Department, Dr Willmar Schwabe, Karlsruhe, Germany
3Clinic for Paediatrics, Evangelic Hospital Hamm, Hamm, Germany
*Corresponding Author: